CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY - News), a leading RNAi therapeutics company, today announced that management will present a company overview at the 10th Annual BIO CEO & Investor Conference on Monday, February 11, 2008, at 1:15 p.m. ET at the Waldorf-Astoria in New York City.
